Stifel Financial
PBYI icon

Stifel Financial’s Puma Biotechnology PBYI Stock Holding History

Stifel Financial’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-6,038
Closed -$356K – 2805
2018
Q2 		$356K Sell
6,038
-2,452
-29% -$142K ﹤0.01% 2197
2018
Q1 		$578K Buy
8,490
+5,452
+179% +$408K ﹤0.01% 1886
2017
Q4 		$298K Buy
3,038
+1,294
+74% +$145K ﹤0.01% 2216
2017
Q3 		$209K Sell
1,744
-996
-36% -$92.6K ﹤0.01% 2349
2017
Q2 		$240K Buy
+2,740
New +$153K ﹤0.01% 2247
2014
Q4 		– Sell
-22,552
Closed -$5.38M – 2412
2014
Q3 		$5.38M Sell
22,552
-55,869
-71% -$11.5M 0.05% 447
2014
Q2 		$5.17M Buy
78,421
+24,396
+45% +$1.73M 0.05% 449
2014
Q1 		$5.63M Buy
+54,025
New +$6.35M 0.05% 402

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Stifel Financial's PBYI Position: Q3 2018 in Review

Stifel Financial sold out of Puma Biotechnology (PBYI) in Q3 2018, closing a stake of 6,038 shares — an estimated $356K sold.

Stifel Financial first reported a position in PBYI in Q1 2014 and held it in 8 quarters. The position peaked at $5.63M in Q1 2014. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2018.

  • Stifel Financial reported no remaining Puma Biotechnology position as of Q3 2018 after selling out during the quarter.
  • Stifel Financial sold 6,038 Puma Biotechnology shares in Q3 2018, an estimated $356K.
  • Stifel Financial first reported a position in Puma Biotechnology in Q1 2014 and held it in 8 quarters.
  • Stifel Financial's Puma Biotechnology position peaked at $5.63M in Q1 2014.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2018.

Based on Stifel Financial's 13F filing for Q3 2018, filed 13 Nov 2018.